Stevens Christopher James has filed 4 insider transactions across 1 company since August 2025.
Most recent transaction: a grant/award of 61963 shares of ROCKET PHARMACEUTICALS, INC. ($RCKT) on February 11, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 11, 2026 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Stevens Christopher James | Chief Operating Officer | A | Common Stock | 61963 | $0.00 | 469,129.0000 | 111,571,136 | 15.22% | 0.06% |
| Feb. 11, 2026 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Stevens Christopher James | Chief Operating Officer | A | Stock Option (Right to Buy) | 93037 | $0.00 | 93,037.0000 | 111,571,136 | 9999.99% | 0.08% |
| Aug. 4, 2025 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Stevens Christopher James | Chief Operating Officer | A | Common Stock | 407166 | $0.00 | 407,166.0000 | 94,807,773 | 9999.99% | 0.43% |
| Aug. 4, 2025 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Stevens Christopher James | Chief Operating Officer | A | Stock Option (Right to Buy) | 554071 | $0.00 | 554,071.0000 | 94,807,773 | 9999.99% | 0.58% |